Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease

Brain Pathology

Volumn 17, Issue 1, 2007, Pages 31-37

  Maat Schieman, Marion ^a   Roos, Raymund ^a   Losekoot, Monique ^a   Dorsman, Josephine ^a   Welling Graafland, Corrie ^a   Hegeman Kleinn, Ingrid ^a   Broeyer, Freerk ^a   Breuning, Martijn ^a   Van Duinen, Sjoerd ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOPSY; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC ANALYSIS; HUMAN; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; MALE; NEOCORTEX; NEUROPIL; PATHOGENESIS; RISK; SCHOOL CHILD;

ADULT; AGED; DNA REPEAT EXPANSION; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; INTRANUCLEAR INCLUSION BODIES; MALE; MIDDLE AGED; NEOCORTEX; NEOSTRIATUM; NEUROPIL;

EID: 33847233319     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2006.00040.x     Document Type: Article

References (51)

1. Bauer P, Laccone F, Rolfs A, Wüllner U, Bösch S, Peters H, Liebscher S, Scheible M, Epplen JT, Weber BHF, Holinski-Feder E, Weinrich-Schwaiger H, Morris-Rosendahl DJ, andrich J, Riess O (2004) Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet 41:230-232.
2. Becher MW, Rubinsztein DC, Leggo J, Wagster MV, Stine OC, Ranen NG, Franz ML, Abbott MH, Sherr M, MacMillan JC, Barron L, Porteous M, Harper PS, Ross CA (1997) Dentatorubral and pallioluysian atrophy (DRPLA). Mov Disord 12:519-530.
3. Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA (1998) Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 4:387-397.
4. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134.
5. Bruni AC, Takahashi Fujigasaki J, Maltecca F, Foncin JF, Servadio A, Casari G, D'Adamo P, Maletta R, Curcio SAM, De Michele G, Filla A, El Hachimi KH, Duyckaerts C (2004) Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 61:1314-1320.
6. Cammarata S, Tabaton M (1992) Ubiquitin-reactive axons have a widespread distribution and are unrelated to prion protein plaques in Creutzfeldt-Jakob disease. J Neurol Sci 110:32-36.
7. Caramins M, Halliday G, McCusker E, Trent RJ (2003) Genetically confirmed clinical Huntington's disease with no observable cell loss. J Neurol Neurosurg Psychiatry 74:968-970.
8. Charles V, Mezey E, Reddy PH, Dehejia A, Young TA, Polymeropoulos MH, Brownstein MJ, Tagle DA (2000) Alpha-synuclein immunoreactivity of Huntington polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models. Neurosci Lett 289:29-32.
9. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wankner EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548.
10. Davies SW, Turmaine M, Cozens BA, Raza AS, Mahal A, Mangiarini L, Bates GP (1999) From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354:971-979.
11. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen SH (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63:87-99.
12. Dickson TC, King CE, McCormack GH, Vickers JC (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Exp Neurol 156:100-110.
13. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel J-P, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993.
14. Everett CM, Wood NW (2004) Trinucleotide repeats and neurodegenerative disease. Brain 127:2385-2405.
15. Fujigasaki H, Martin J-J, De Deyn PP, Camuzat A, Deffond D, Stevanin G, Dermaut B, Van Broeckhoven C, Dürr A, Brice A (2001) CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124:1939-1947.
16. Gómez-Tortosa E, MacDonald ME, Friend JC, Taylor SAM, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel J-P, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 49:29-34.
17. Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw J-J, Trottier Y, Brice A, Agid Y, Hirsch EC (1998) Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset. NeuroReport 9:1823-1826.
18. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ (2006) Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243-255.
19. Gutekunst C-A, Li S-H, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li X-J (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19:2522-2534.
20. Hayashi Y, Kakita A, Yamada M, Koide R, Igarashi S, Takano H, Ikeuchi T, Wakabayashi K, Egawa S, Tsuji S, Takahashi H (1998) Hereditary dentatorubral-pallidoluysian atrophy: detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain. Acta Neuropathol 96:547-552.
21. Jackson M, Gentleman S, Lennox G, Ward L, Gray T, Randall K, Morrel K, Lowe J (1995) The cortical neuritic pathology of Huntington's disease. Neuropathol Appl Neurobiol 21:18-26.
22. Kakita A, Oyanagi K, Nagai H, Takahashi H (1997) Eosinophilic intranuclear inclusions in the hippocampal pyramidal neurons of a patient with amyotrophic lateral sclerosis. Acta Neuropathol 93:532-536.
23. Kambouris M, Bohlega S, Al-Tahan A, Meyer BF (2000) Localization of the gene for a novel autosomal recessive neurodegenerative huntingtonlike disorder to 4p15.3. Am J Hum Genet 66:445-452.
24. Katsuse O, Dickson DW (2005) Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease. Alzheimer Dis Assoc Disord 19:S37-S43.
25. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, anderson DW (1996) Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 55:97-105.
26. Maat-Schieman MLC, Dorsman JC, Smoor MA, Siesling S, Van Duinen SG, Verschuuren JJGM, Den Dunnen JT, Van Ommen G-J, Roos RAC (1999) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 58:129-137.
27. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson J, Feldman H, Lindholm C, Melquist S, Pettman R, Dessa Sadovnick A, Dwosh E, Whiteheart SW, Hutton M, Pickering-Brown SM (2006) A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129:853-867.
28. Margolis RL, Rudnicki DD, Holmes SE (2005) Huntington's disease like-2: review and update. Acta Neurol Taiwan 14:1-8.
29. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM-Y, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 65:1863-1872.
30. Meenakshi-Sundaram S, Arun Kumar MJ, Sridhar R, Rani U, Sundar B (2004) Neuroacanthocytosis misdiagnosed as Huntington's disease: a case report. J Neurol Sci 219:163-166.
31. Moore RC, Xiang F, Monaghan J, Han D, Zhang Z, Edström L, Anvret M, Prusiner SB (2001) Huntington disease phenocopy is a familial prion disease. Am J Hum Genet 69:1385-1388.
32. Paviour DC, Lees AJ, Josephs KA, Ozawa T, Ganguly M, Strand C, Godbolt A, Howard RS, Revesz T, Holton JL (2004) Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive changes: broadening the clinical picture to include progressive supranuclear palsy. Brain 127:2441-2451.
33. Persichetti F, Srinidhi J, Kanaley L, Ge P, Myers RH, D' Arrigo K, Barnes GT, MacDonald ME, Vonsattel J-P, Gusella JF, Bird ED (1994) Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains. Neurobiol Dis 1:159-166.
34. Piao Y-S, Wakabayashi K, Kakita A, Yamada M, Hayashi S, Morita T, Ikuta F, Oyanagi K, Takahashi H (2003) Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 12:10-22.
35. Richfield EK, Vonsattel J-P, MacDonald ME, Sun Z, Deng Y-PP, Reiner A (2002) Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease. Mov Disord 17:327-332.
36. Rinne JO, Daniel SE, Scaravilli F, Pires M, Harding AE, Marsden CD (1994) The neuropathological features of neuroacanthocytosis. Mov Disord 9:297-304.
37. Sapp E, Penney J, Young A, Aronin N, Vonsattel J-P, DiFiglia M (1999) Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 58:165-173.
38. Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, Slunt HH, Ratovitski T, Cooper JK, Jenkins NA, Copeland NG, Price DL, Ross CA, Borchelt DR (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Gen 8:397-407.
39. Seilhean D, Takahashi J, El Hachimi KH, Fujigasaki H, Lebre A-S, Biancalana V, Dür A, Salachas F, Hogenhuis J, de Thé H, Hauw J-J, Meininger V, Brice A, Duyckaerts C (2004) Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol 108:81-87.
40. Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N, Mann DMA (1999) Huntington's disease intranuclear inclusions contain truncated ubiquitinated huntingtin protein. Exp Neurol 156:92-99.
41. Siesling S, Vegter-van de Vlis M, Losekoot M, Belfroid RD, Maat-Kievit JA, Kremer HP, Roos RA (2000) Family history and DNA analysis in patients with suspected Huntington's disease. J Neurol Neurosurg Psychiatry 69:54-59.
42. Stevanin G, Fujigasaki H, Lebre A-S, Camuzat A, Jeannequin C, Dodé C, Takahshi J, Sân C, Bellance R, Brice A, Durr A (2003) Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599-1603.
43. Stevenson VL, Hardie RJ (2001) Acanthocytosis and neurological disorders. J Neurol 248:87-94.
44. Takahashi-Fujigasaki J (2003) Neuronal intranuclear hyaline inclusion disease. Neuropathology 23:351-359.
45. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group (1998) Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 62:1243-1247.
46. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
47. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease (1997) Consensus recommedations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18:S1-S2.
48. Turmaine M, Raza A, Mahal A, Mangiarini L, Bates GP, Davies SW (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci USA 97:8093-8097.
49. Vonsattel J-P, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
50. Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE (2001) Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol Biol Cell 12:1393-1407.
51. Xuereb JH, MacMillan JC, Davies P, Harper PS (1996) Neuropathological diagnosis and CAG repeat expansion in Huntington's disease. J Neurol Neurosurg Psychiatry 60:78-81.